Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted-4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants

European Journal of Medicinal Chemistry

Volumn 44, Issue 3, 2009, Pages 1135-1143

  Wagle, Shivananda ^a   Adhikari, Airody Vasudeva ^b   Kumari, Nalilu Suchetha ^c  

^a Strides Research and Specialty Chemicals Ltd   (India)

^b NATIONAL INSTITUTE OF TECHNOLOGY KARNATAKA   (India)

^c NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

1,2,4 Triazolo; Anticonvulsant activity; Hydrazones; Quinoxaline; Styryl; Tetrazolo

Indexed keywords

1,4 DIMETHYL[1,2,4]TRIAZOLO[4,3 A]QUINOXALINE; 2 CHLORO 3 METHYLQUINOXALINE; 2 HYDRAZINO 3 METHYLQUINOXALINE; 4 METHYL 1 (TRIFLUOROMETHYL)[1,2,4]TRIAZOLO[4,3 A]QUINOXALINE; 4 METHYL [1,2,4]TRIAZOLO[4,3 A]QUINOXALINE DERIVATIVE; 4 METHYL[1,2,4]TRIAZOLO[4,3 A]QUINOXALINE DERIVATIVE; 4 METHYLTETRAZOLO[1,5 A]QUINOXALINE; 4 STYRYL[1,2,4]TRIAZOLO[4,3 A]QUINOXALINE DERIVATIVE; 4 STYRYLTETRAZOLO[1,5 A]QUINOXALINE DERIVATIVE; [1,2,4]TRIAZOLO[4,3 A]QUINOXALINE DERIVATIVE; DIAZEPAM; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VIVO STUDY; INFRARED SPECTROSCOPY; MALE; MOUSE; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE; SUBSTITUTION REACTION;

ANIMALS; ANTICONVULSANTS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; QUINOXALINES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 60549087348     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.06.006     Document Type: Article

References (27)

1. Herbst R.M. In: Groff S. (Ed). Essays in Biochemistry (1956), John Wiley, New York 141
2. Shekarchi M., Marvasti M.B., Sharifzadeh M., and Shafiee A. Iran. J. Pharm. Res. 1 (2005) 33-36
3. Kumar P., and Knaus E.E. Drug Des. Discov. 11 (1994) 15-19
4. Chem. Abstr. 121 (1994) 194945x
5. Shukla J.S., and Saxena S. Indian Drugs 18 (1980) 15-21
6. Chem. Abstr. 94 (1981) 10787s
7. Ko O.H., Kang H.R., Yoo J.C., Kim G.S., and Hong S.S. Yakhak Hoechi 36 (1992) 150-153
8. Chem. Abstr. 121 (1994) 280436p
9. N. Dereu, M. Evers, C.Poujade, F. Soler, PCT Int. Appl. WO 9426725, 1994
10. Chem. Abstr. 122 (1995) 214297p
11. Singh H., Bhutani K.K., Malhotra R.K., and Paul D. Experientia 34 (1978) 557-564
12. J. Chem. Soc., Perkin Trans. I (1979) 3166-3171
13. Kim H.S., Kim T.E., and Kurasawa Y. J. Korean Chem. Soc. 45 (2001) 325-333
14. Potts K.T. Chem. Rev. 61 (1961) 87-127
15. Xie Z.F., Chai K.Y., Piao H.R., Kwak K.C., and Quan Z.S. Bioorg. Med. Chem. Lett. 15 (2005) 4803-4805
16. Ilkay K., Kucukguzel S.G., Rollas S., Gulten O.S., Ozdemir O., Bayrak I., Aitug T., and Stables J.P. Il Pharmaco. 59 (2004) 893-901
17. Chimirri A., Gitto R., Quartarone S., Orlando V., De Sarro A., and De Sarro G.B. Il Pharmaco. 57 (2002) 759-763
18. Dawood K.M., Abdel-Gawad H., Rageb E.A., Ellithey M., and Mohamed H.A. Bioorg. Med. Chem. 14 (2006) 3672-3680
19. Ali A., Sayyed A.T., Mehrdad F., Abbas K., Nazila M., Afshin D., and Abbas S. Bioorg. Med. Chem. Lett. 14 (2004) 6057-6059
20. J.B. Bicking, US Patent 2917511, 15 Dec, 1959
21. Chem. Abstr. 54 (1960) 8854
22. B.K. Trivedi, US Patent 4780464, 25 Oct, 1988.
23. El-Bendary E.R., Goda F.E., Maarouf A.R., and Badria F.A. Sci. Pharm. 72 2 (2004) 175-185
24. Vida J.A. Anticonvulsants. In: Foye W.O., Lemke T.L., and Williams D.A. (Eds). Principles of Medicinal Chemistry (1995), Williams and Wilkins, London
25. Makino K., Sakata G., Morimoto K., and Ochiai Y. Heterocycles 23 8 (1985) 2025-2034
26. Sarges R., Howard H.R., Browne R.G., Lebel L.A., Seymour P.A., and Koe B.K. J. Med. Chem. 33 (1990) 2240-2254
27. Guan L., Jin Q., Tian G., Chai K., and Quan Z. J. Pharm. Pharm. Sci. 10 3 (2007) 254-262